Drugs & Targets Concerto HealthAI collaborates with Pfizer, Janssen; launches eurekaHealth 3.0 January 17, 2020Vol.46 No.03
Drugs & Targets Roche, Illumina collaborate to broaden patient access to genomic testing January 17, 2020Vol.46 No.03
Drugs & Targets Qiagen, Amgen collaborate on companion diagnostic development in NSCLC January 17, 2020Vol.46 No.03
Drugs & Targets FDA approves Keytruda for BCG-unresponsive, high-risk non-muscle invasive bladder cancer January 10, 2020Vol.46 No.02
Drugs & Targets FDA approves Ayvakit for unresectable or metastatic PDGFRA Exon 18 mutant gastrointestinal stromal tumor January 10, 2020Vol.46 No.02
Drugs & Targets Enfortumab vedotin gets FDA accelerated approval for advanced urothelial or bladder cancer January 10, 2020Vol.46 No.02
Drugs & Targets FDA grants IceCure clearance for expanded indications of cryoablation technology and regulatory approval of MultiSense system January 10, 2020Vol.46 No.02
Drugs & Targets Canada approves treatment for relapsed/refractory chronic lymphocytic leukemia as part of Project Orbis collaboration January 10, 2020Vol.46 No.02
Drugs & Targets FDA approves Lynparza as first-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer January 03, 2020Vol.46 No.01
Drugs & Targets FDA approves Xtandi for metastatic castration-sensitive prostate indication January 03, 2020Vol.46 No.01
